Anemia
Burrill Reports Biotech Hit By Market Jitters in July
Published in Hematology Week, August 13th, 2007
"Biotech had to weather a bumpy ride in the wake of nervous investors and skittish general markets," said G. Steven Burrill, CEO, Burrill & Company, a San Francisco based global leader in life sciences whose principal activities are in Venture Capital, Merchant Banking and Media. "It was an unusual month to say the least with the Dow just breaking through the 14,000 mark before falling dramatically to finish at 13,212 as weak economic data and ongoing credit concerns overshadowed more positive news on the earnings front."
The Dow closed the month down almost 1.5% and the NASDAQ down 2%. The Burrill Biotech Select Index held its own in July. Helping the cause was Vertex...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hematology Week
Source: Hematology Week (2007-08-13)
More Articles from Hematology Week
- Anemia
Nutritional supplement cuts anemia in poor children by half - Leukemia
U-M team identifies gene that regulates blood-forming fetal stem cells - Obstetrics
MGH researchers confirm that bone marrow restores fertility in female mice - Cancer
City of Hope Celebrates 'La Gota de la Vida Campaign' With Cristian Castro, Graciela Beltran and Alejandro Lerner as Festival Headliners - Erythropoiesis
Amgen Responds to Final CMS National Coverage Determination on Use of Erythropoiesis-Stimulating Agents in Oncology - Leukemia
Sunesis Pharmaceuticals Reports Second Quarter 2007 Financial Results - More from this issue of Hematology Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
